GTx
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch GTx and buy or sell other stocks, ETFs, and their options commission-free!About GTXI
Oncternal Therapeutics, Inc. engages in the development of novel oncology therapies for the treatment of cancers with critical unmet medical need. Its product pipeline include Zilovertamab, ONCT-216, ONCT-808 and ONCT-534.
CEOJames B. Breitmeyer, MD, PhD
CEOJames B. Breitmeyer, MD, PhD
Employees—
Employees—
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded1997
Founded1997
Employees—
Employees—
GTXI Key Statistics
Market cap—
Market cap—
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume—
Average volume—
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.5266
52 Week high$0.5266
52 Week low$0.5266
52 Week low$0.5266
Stock Snapshot
GTx(GTXI) stock is priced at $3.94.
On 2026-10-23, GTx(GTXI) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0.
The stock's 52-week range extends from a low of $0.53 to a high of $0.53.
The stock's 52-week range extends from a low of $0.53 to a high of $0.53.